Fungi have emerged as major causes of human diseases. Intensive Care Units (ICU), harbor almost all the risk factors for opportunistic fungal infections. Among these, Candida infections are very common with recent trends being rise in the non-Candida albicans (NCA) species along with an increase in resistance of these species to antifungal drugs.
Introduction
For over 20 years, Candida bloodstream infections (BSIs) have been increasing significantly worldwide, representing an important infective complication in hospitalized patients with medical and surgical disorders [1] . Candida spp. especially Candida albicans consider as one of the most common cause of fungal infections leading to a range of lifethreatening invasive too non-lifethreatening mucocutaneous diseases [2] . According to nosocomial Infection Surveillance systems of the United State, candida spp. is the 7th most common nosocomial pathogens [3] . There are several Candida species involve in causing disease, but the most commonspecies is Candida albicans. Many other documents and records are showing the increasing incidence of other nonalbicans among hospitalised and immune suppressed patients. The emergence of this opportunistic pathogen is favoured by the change in the most susceptibility due to the growing number of immune compromised individuals in the population as a result of HIV pandemic and the use of long-term immunosuppressive therapy in cancer and organ transplant patients [4] . Candida infection in hospitalized patient is increasing significantly over the last 10 years. Particularly the patients in the Intensive Care Unit who have invasive monitoring lines. Candida infection leading to prolonged hospitalization and significant mortality which dictate the need to take all the possible measures to prevent this infection particularly at the high risk patients. Among the ICU patients Candida bloodstream infection has become the fourth common organism because of the invasive infection in critical patients) [5, 6] . In recent year there has been increase in isolation of other species from neonate's patients but still the Candida albicans is the most common one with invasive Candidiasis [7] . The causative agents of bloodstream infection is most commonly by Candida albicans with prevalence rate is near by 50%) [8] . The increasing nosocomial UTI subgroups is because of fungal infection and all fungal UTI are due to Candida species) [9] . 
Materials and Methods

Discussion
Candida species are the most common cause of fungal infections, leading to a range of life-threatening invasive too nonlife-threatening mucocutaneous diseases. The species are endogenous in nature and are usually responsible for opportunistic infections. In addition, using several broad spectrum antibiotics, immunosuppressive and corticosteroids drugs in ICUs and NICUs wards, were increased candiduria. During the several last decades, an increasing in several opportunistic fungal infection was observed. This is newly recognized opportunistic pathogen that has been linked too oropharyngeal Candidiais in HIV-infected patients. It has also been observed in blood isolates from bone marrow transplant patients, denture wearers, cancer patients, infants and elderly, oral and vaginal isolates from non-HIV-infected patients [5, 6, 7] . In this study total 186 patient's samples were screened, out of these 50 were positive for Candida. Candida was mainly isolated from blood (74%) and urine (18%) & ET Tube 8%. Candida albicans, Candida tropicalis, Candida glabrata causes 44%, 26% and 18% of the infections respectively. Our study shows Candidaalbicans is the most predominant one. Candida species are the 4 th most causative agents of bloodstream infection in hospitalised patients due to the normal microbes of human, which enhance to colonise the implanted devices of the host [12] . Although there is low sensitivity of conventional culture to detect yeast but the invasive nature of the fungi causing opportunistic infecting which causes morbidity and mortality in hospitalized patients. The main aim of our study is to show the morbidity of fungal infection in ICU patients [13] . The advance technique of modern medicine is able to treat many kinds of disease. The incidence of nosocomial infection of the fungi have been increasing due to immunosuppressive drugs,use of broad-spectrum antibiotics, indwelling devices, prolonged stay in the ICU, intra-abdominal surgery, immunocompromised and immunosuppressive drugs [14] .Various reports regarding the prevalence of Candida albicans and nonCandida albicans bloodstream infection have been reported from India. From the neonates Candida albicans as the most common isolates Candida few case have documented [15, 16] . Candida bloodstream infection has become challenge in critically ill patient due to immuno-compromised, diabetes, intravenous cannulae, and intravenous drug use) [17] . Candidiasis is most commonly seen in ICUs patients. C. albicans is the predominant cause of Candida bloodstream infection [18] . The major component of cell membrane is phospholipids which is catalyses by phospholipase which acts as a virulent factor and due to this there was hydrolysis of phospholipids and lyses of cell [19] . Invasive fungal infections caused by a variety of fungal species are becoming an increasing problem worldwide. In particular, Candida species have become the seventh most common cause of nosocomial sepsis in children [20] .ICU patients are at higher risk for Invasive Candidiasis than patients the general ward patients [21] .Among the known risk factors for Invasive Candidiais, colonization is the most important one as it indicates that patients have an endogenous source of candida [22] .The present study highlights the change in epidemiology in the species distribution of Candida and also highlights a rise in the infections by NCA species as compared to those by C. albicans, along with an increase in resistance of these NCA species to the routinely used antifungals. Therefore, knowledge of the local species distribution of Candida through presumptive identification, followed by confirmation, is essential to initiate early empirical therapy, especially in an ICU setup, which harbors a lot of immunocompromised patients and other patients susceptible for acquiring various fungal infections. Moreover, antifungal susceptibility testing, though not as routinely performed as antibacterial susceptibility testing, should be carried out, along with MIC values of the isolates for the various groups of antifungals, in order to optimize therapy and outcome. Conclusion This study demonstrates the importance of species identification and antifungals usceptibility testing for hospitalized patients in ICUs and NICUs wards. In the NICU, it is associated with a very high mortality, especially with antibiotic uses. Major risk factors are prolonged ventilation (>7 days). Antenatal care has a protective impact on neonatal fungal infection in our settings.
